METHOD OF TREATING LUNG CANCER BY VACCINATION WITH MUC-1 LIPOPEPTIDE
摘要
The invention is directed to the treatment of lung cancer, preferably non-small cell lung cancer (NSCLC) by means of a combination therapy comprising concurrent chemo-radiotherapy followed by vaccination with a muc-1 lipopetide. The therapy elicits prolonged survival rates compared to a respective therapy including sequential chemo-radiotherapy.
申请公布号
CA2912269(A1)
申请公布日期
2014.11.20
申请号
CA20142912269
申请日期
2014.04.14
申请人
MERCK PATENT GMBH
发明人
SCHROEDER, ANDREAS;HELWIG, CHRISTOPH;LOOS, ANJA-HELENA;SCHUELER, ARMIN;FALK, MARTIN;BUTTS, CHARLES;SHEPHERD, FRANCES A.